Details for Patent: 10,849,919
✉ Email this page to a colleague
Which drugs does patent 10,849,919 protect, and when does it expire?
Patent 10,849,919 protects MAVENCLAD and is included in one NDA.
This patent has fourteen patent family members in fourteen countries.
Summary for Patent: 10,849,919
Title: | Cladribine regimen for treating progressive forms of multiple sclerosis |
Abstract: | Specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine can be effective for the treatment of progressive forms of Multiple Sclerosis, especially Primary Progressive Multiple Sclerosis and/or Secondary Progressive Multiple Sclerosis. Methods of treatment can be based on specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine. |
Inventor(s): | Dangond; Fernando (Weston, MA), Dotzauer; Matthias (Erzhausen, DE) |
Assignee: | Merck Patent GmbH (Darmstadt, DE) |
Application Number: | 16/199,119 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 10,849,919
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emd Serono Inc | MAVENCLAD | cladribine | TABLET;ORAL | 022561-001 | Mar 29, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATING NON-EARLY SPMS BY ADMINISTERING ORAL CLADRIBINE AT A FIXED DOSE PER PATIENT, PER BODY WEIGHT AND PER TREATMENT YEAR, WHICH FIXED DOSE IS 1.75 +/- 0.2 MG/KG, TO BE ADMINISTERED WITHIN MONTHS 1 AND 2 IN EACH OF 2 ADJACENT TREATMENT YEARS | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,849,919
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 113906 | ⤷ Try a Trial | |||
Australia | 2018372007 | ⤷ Try a Trial | |||
Brazil | 112020010282 | ⤷ Try a Trial | |||
Canada | 3083328 | ⤷ Try a Trial | |||
China | 111356460 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |